From pharmaceuticals to financial services, the motives that drive outsourcing are fundamental. Top among them are perceived cost savings, improved...

Working on the Rare Disease Science Challenge has shown me that everybody wants to support rare disease in many different ways, which is how the...

Last week we blogged about the growing trend in pharmaceutical outsourcing. When people hear the word “outsourcing”, many assume that means that...

Washington University geneticist Dr. Jimmy Lin’s Rare Genomics Institute and Scientist of San Diego have announced the winners of about $500,000 in...

The Be HEARD Rare Disease Science Challenge is entering its next phase. After 77 applicants covering 67 rare diseases, we have decided on service...

By some estimates, the pharmaceutical outsourcing market could grow to $65 billion by 2018, fueled by a compound annual growth rate of nearly 15...

I’m sure it comes as no surprise to anyone reading this article that we have a problem in drug development. Pharmaceutical companies are having to...

Rare diseases by definition only affect a small number of people, but rare disease studies can reveal valuable information for more common...

This article discusses how the pharmaceutical industry can leverage its competencies in outsourcing to accelerate time to market, improve quality...

Recently, Oxbridge Biotech Roundtable (OBR) interviewed Scientist’s Kevin Lustig about how his career decisions and approach to research shaped his...